NO20013015D0 - Liposominfluminsyre - ny transdermal antiinflammatorisk medisin - Google Patents

Liposominfluminsyre - ny transdermal antiinflammatorisk medisin

Info

Publication number
NO20013015D0
NO20013015D0 NO20013015A NO20013015A NO20013015D0 NO 20013015 D0 NO20013015 D0 NO 20013015D0 NO 20013015 A NO20013015 A NO 20013015A NO 20013015 A NO20013015 A NO 20013015A NO 20013015 D0 NO20013015 D0 NO 20013015D0
Authority
NO
Norway
Prior art keywords
inflammatory
liposomine
acid
new transdermal
drug
Prior art date
Application number
NO20013015A
Other languages
English (en)
Other versions
NO20013015L (no
Inventor
Konstantinos Demetzos
Helen Kammenou
Michalis Rallis
Georgios Papaioannou
Aristidis Georgopoulos
Georgios Tsamouris
Sofia Hatziantoniou
Georgios Giannisis
Georgios Nounesis
Christina Savva Dimopoulou
Original Assignee
P N Gerolymatos Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by P N Gerolymatos Sa filed Critical P N Gerolymatos Sa
Publication of NO20013015D0 publication Critical patent/NO20013015D0/no
Publication of NO20013015L publication Critical patent/NO20013015L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
NO20013015A 1998-12-24 2001-06-18 Liposominfluminsyre - ny transdermal antiinflammatorisk medisin NO20013015L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR98100469 1998-12-24
PCT/GR1999/000048 WO2000038681A1 (en) 1998-12-24 1999-12-22 Liposomic niflumic acid - new transdermal anti-inflammatory medicine

Publications (2)

Publication Number Publication Date
NO20013015D0 true NO20013015D0 (no) 2001-06-18
NO20013015L NO20013015L (no) 2001-06-18

Family

ID=10943556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013015A NO20013015L (no) 1998-12-24 2001-06-18 Liposominfluminsyre - ny transdermal antiinflammatorisk medisin

Country Status (17)

Country Link
EP (1) EP1140089A1 (no)
JP (1) JP2002533394A (no)
KR (1) KR20010089889A (no)
CN (1) CN1331592A (no)
AU (1) AU1673400A (no)
BR (1) BR9917006A (no)
CA (1) CA2357765A1 (no)
CZ (1) CZ20012240A3 (no)
GR (1) GR1003359B (no)
HU (1) HUP0104853A3 (no)
IL (1) IL143499A0 (no)
IS (1) IS5964A (no)
MX (1) MXPA01006462A (no)
NO (1) NO20013015L (no)
PL (1) PL349344A1 (no)
SK (1) SK7962001A3 (no)
WO (1) WO2000038681A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004047802A2 (en) * 2002-11-26 2004-06-10 Gilead Sciences, Inc. Liposomal formulations
JP5107573B2 (ja) * 2003-04-25 2012-12-26 ザ ペン ステイト リサーチ ファウンデーション 増殖抑制性脂質由来生物活性化合物の全身送達方法およびシステム
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
JP4791082B2 (ja) * 2005-05-30 2011-10-12 株式会社クラレ リポソームおよびそれを含む皮膚外用剤
JP4931369B2 (ja) * 2005-05-31 2012-05-16 ポーラ化成工業株式会社 リポソームおよびそれを含む処置用の組成物
RU2468797C2 (ru) 2005-06-09 2012-12-10 Биолипокс Аб Способ и композиция для лечения воспалительных нарушений
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
US9144575B2 (en) 2010-07-28 2015-09-29 Life Technologies Corporation Anti-viral azide containing compounds
KR20140129054A (ko) 2012-01-26 2014-11-06 라이프 테크놀로지스 코포레이션 바이러스의 감염성을 증가시키는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
AU587299B2 (en) * 1985-11-27 1989-08-10 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti- inflammatory drug
ES2036593T3 (es) * 1986-06-12 1993-06-01 The Liposome Company, Inc. Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
EP0825852B1 (en) * 1995-04-18 2004-07-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition

Also Published As

Publication number Publication date
CA2357765A1 (en) 2000-07-06
EP1140089A1 (en) 2001-10-10
WO2000038681A1 (en) 2000-07-06
AU1673400A (en) 2000-07-31
SK7962001A3 (en) 2002-02-05
CZ20012240A3 (cs) 2001-11-14
HUP0104853A2 (hu) 2002-05-29
IS5964A (is) 2001-06-08
KR20010089889A (ko) 2001-10-12
MXPA01006462A (es) 2002-06-04
PL349344A1 (en) 2002-07-15
JP2002533394A (ja) 2002-10-08
BR9917006A (pt) 2001-10-30
NO20013015L (no) 2001-06-18
HUP0104853A3 (en) 2003-05-28
GR1003359B (el) 2000-04-10
CN1331592A (zh) 2002-01-16
IL143499A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
PT966430E (pt) Compostos anti-inflamatorios
ATE285405T1 (de) Nichtsteroidale entzündungshemmer
EE200100483A (et) Põletikuvastaste vahenditena kasutatavad ühendid
IS5568A (is) Lyfjafræðilega virkt morfólínól
NO20015175D0 (no) Farmasöytisk sammensetning
DK1637127T3 (da) Terapeutisk mikroskum
IS2277B (is) Meðferðarlegar bíarýl afleiður
NO20021400D0 (no) Terapeutiske konazolinderivater
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
ID27415A (id) Komposisi farmaseutik
NO20031869D0 (no) Antiinflammatoriske midler
FI4150U1 (fi) Elektrodirakenne
ID29262A (id) Komposisi farmasi
NO20022606L (no) Farmasöytiske kombinasjoner
ID27201A (id) Komposisi farmasi
DK1275397T3 (da) Lægemiddel til lokal anvendelse
ID27150A (id) Sediaan levotiroksin bahan farmasi
NO20014926L (no) Farmasöytiske forbindelser
FR2774599B1 (fr) Cataplasme
DE60011330D1 (de) Elektrode
PT1086097E (pt) Compostos sulfonilbenzeno como agentes anti-inflamatorios/analgesicos
NO20013015D0 (no) Liposominfluminsyre - ny transdermal antiinflammatorisk medisin
FI4488U1 (fi) Farmaseuttinen koostumus
IS6163A (is) Lyfjakomplex
ID26215A (id) Komposisi farmasi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application